Could one daily pill narrow the diabetes treatment gap in the Global South?
Full story
Approximately one in nine people worldwide lives with diabetes. Pharmaceutical companies are shifting from injectable treatments toward oral tablets. The change could enable a daily pill to address treatment gaps, especially in developing regions. The article suggests that a single pill might narrow disparities in diabetes care.
Globally, one in nine people lives with diabetes, as blockbuster injectable drugs begin making way for tablets instead.